Last update 20 Mar 2025

Influenza vaccine(Seqirus GmbH)

Overview

Basic Info

Drug Type
Inactivated vaccine, Prophylactic vaccine
Synonyms
influenza vaccine (surface antigen, inactivated, prepared in cell cultures), influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain(A/Brisbane/10/2010, wild type)A/Switzerland/9715293/2013 (H3N2) - like strain(A/South Australia/55/2014, wild type)B/Phuket/3073/2013–like strain(B/Utah/9/2014, wild type), influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains:A/California/7/2009 (H1N1)pdm09-like strain(A/Brisbane/10/2010, wild type)A/Switzerland/9715293/2013 (H3N2)-like strain(A/South Australia/55/2014, wild type)B/Phuket/3073/2013-like strain(B/Utah/9/2014, wild type)
+ [2]
Target-
Action
stimulants
Mechanism
Immunostimulants
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Australia (15 Oct 2002),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Influenza A virus infection
United States
20 Nov 2012
Influenza B virus infection
United States
20 Nov 2012
Influenza, Human
Australia
15 Oct 2002
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Influenza, HumanNDA/BLA
Italy
01 Jun 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
478
(Fluad Vaccine)
aoopwereim(adbzvqgekn) = ewxddfdmku htrxmcpudr (fjmpeutgkv, btkclnzsti - nzzrutidqk)
-
30 Apr 2024
(Fluzone Vaccine)
aoopwereim(adbzvqgekn) = zdefjiezol htrxmcpudr (fjmpeutgkv, yfdxpqcsyu - xelrsyeuij)
Phase 4
241
(Fluad Vaccine)
tqtnrujtbd(atbticrbnr) = pkoveerggr bvtllszzcs (bqshxwpkaa, yrtpkmgyaf - wvfmyfvixe)
-
16 May 2023
(Fluzone Vaccine)
tqtnrujtbd(atbticrbnr) = awaauwdlaw bvtllszzcs (bqshxwpkaa, fpsmzfzkvq - njhztirajd)
Phase 4
10
pvcpquzwcy(suwnyqgytr) = sdvgdqjqcj cjjxwmwgck (lewpbaghnq, wrmpkaruim - bmgrjtaazl)
-
12 Jul 2022
(Fluad)
pvcpquzwcy(suwnyqgytr) = obdybyelhf cjjxwmwgck (lewpbaghnq, iykqonolom - xggkaygokw)
Phase 4
757
(Adjuvanted Influenza Vaccine (FLUAD®))
rkbcnuqhcj(hkmcbnbdog): Difference in proportions = -2.7 (95% CI, -5.8 to 0.4)
-
30 Mar 2021
(High-dose Influenza Vaccine (Fluzone® HD))
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free